Key points: In a limited subset of patients, dupilumab-induced hypereosinophilia is persistent. Two-month follow-up eosinophil count may predict long-lasting hypereosinophilia.
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study / Rampi, A.; Tanzini, U.; Vinciguerra, A.; Dane, G.; Moroni, L.; Yacoub, M. -R.; Trimarchi, M.. - In: INTERNATIONAL FORUM OF ALLERGY AND RHINOLOGY. - ISSN 2042-6976. - 13:12(2023), pp. 2244-2247. [10.1002/alr.23212]
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study
Rampi A.Primo
;Tanzini U.Secondo
;Vinciguerra A.;Moroni L.;Yacoub M. -R.Penultimo
;Trimarchi M.
Ultimo
2023-01-01
Abstract
Key points: In a limited subset of patients, dupilumab-induced hypereosinophilia is persistent. Two-month follow-up eosinophil count may predict long-lasting hypereosinophilia.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Int Forum Allergy Rhinol - 2023 - Rampi - Early increase in eosinophil count may predict long‐term hypereosinophilia during.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
322.16 kB
Formato
Adobe PDF
|
322.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
